However, recent studies have shown that ZFAS1 is upregulated in multiple types of tumors, including hepatocellular carcinoma, gastric cancer, and colorectal cancer [19–22], suggesting that ZFAS1 may serve as a proto-oncogene, and a prognostic biomarker in cancer. The gene discussed is ZFAS1; the disease is gastric cancer.